Patrick Flochel

Supervisory Board member Access to Medicine Foundation, retired EY partner and former Global Pharmaceutical sector leader.

[Access to Medicine Foundation @AtMIndex]

#AMR is rising faster than expected & #pharma companies’ role in helping to curb it has never been more critical. W/ support from policymakers & investors, pharma industry must now accelerate its efforts against this #GlobalHealth threat. Read more 👉 https://t.co/B27IEB1mES

[Brennan Spiegel, MD, MSHS @BrennanSpiegel]

Doctors from around the world converged at #CedarsSinai last week to learn how #VR, #AR & #MR are being used in healthcare. Amazing energy at our "Virtual Medicine" conference as we explored the future of medicine in the #Metaverse. Thanks to the >370 registrants who joined.

[Jayasree Iyer @JayasreeKIyer]

Great news from Phase II/III study on Acoziborole, a single-dose oral med for #sleepingsickness. Treatment success rates of up to 95%.
@BillGates #beatNTDs

[Access to Medicine Foundation @AtMIndex]

Our #ATMI22 launch event brought together 150+ participants to discuss #access2meds in #LMICs.

Thank you to our all-women expert panel for an excellent discussion on the key takeaways from the #COVID19 pandemic & #ATMI22 findings.

@DrZSB @DrEmeruemJnr @lwazimanzi @SaveCEO_UK

[Jayasree Iyer @JayasreeKIyer]

How have pharma co.s performed on #access2meds during #COVID19? The latest #ATMI22 is now out w/ fresh insights + 3 special reports covering industry progress, #pandemic preparedness and #SRHR @JeremyFarrar @GinaAgios @LSchreinemacher @JamesCleverly @jarottingen @AndrewmitchMP

[Eva Bester @evabester]

Ma chronique de début d’émission portait sur le prière d'insérer de Blaise Cendrars pour son livre Le Lotissement du ciel (1949)

[Suzanne Wolf @SuzanneWolfATMI]

Looking forward to seeing the outcomes of the roundtable @JayasreeKIyer @EmmaCahuzac @rosswrite_SW1 @VerhoefMarijn #medicaloxygen

[Access to Medicine Foundation @AtMIndex]

Millions of people with #diabetes in #LMICs have no #AccessToInsulin & choice of treatment options. Our report published today looks at how pharma companies can close the #insulin access gap 👉 https://t.co/Wy4JrPwxfD
@HelmsleyTrust @gatesfoundation @FCDOGovUK @DutchMFA @AXAIM

[Jayasree Iyer @JayasreeKIyer]

Our latest study on access to #diabetes care will be released tomorrow. Stay tuned...
@katiedain1 @HelmsleyTrust @IntDiabetesFed @WorldDiabetesF

[Access to Medicine Foundation @AtMIndex]

To turn our insights into positive change, we engage with pharma companies directly, sharing the Foundation’s research and discussing opportunities and best practices. Our Amsterdam Sessions provide a forum for companies to learn from each other.

More👇https://t.co/0gELBbIiNw

[Access to Medicine Foundation @AtMIndex]

Investors are strongest when they pool their influence. Joining our collaborative initiatives means they can steer pharma companies to do better. @Candriam supports our goal to improve #LMIC access to medicine in line with UN’s #SDG3.

More for investors👇https://t.co/cPb0ppKfWt

[Geopragma @PoleGeopragma]

📖 Guerre en Ukraine : le jeu sino-américain

Billet d'humeur, rédigé par Renaud Girard, membre du Comité d’orientation stratégique de Geopragma.

https://t.co/OI58QfJ0k1

[Patrick Flochel @patrickflochel]

Insulin Belongs to the World by Jayasree K. Iyer @ProSyn https://t.co/qPqY0NiSJf

[Paul Melun @PaulMelun]

La fameuse solidarité européenne, épisode 61737188

[Access to Medicine Foundation @AtMIndex]

Today #WorldCancerDay focuses on the equity gap within cancer care - 10 mil die each year from cancer, 70% in lower-income countries. Our Index lays out missed chances for #pharma to use equitable pricing to #CloseTheCareGap👉https://t.co/DhDLF53Kty

[Patrick Flochel @patrickflochel]

Biotech pipeline is outpaced by antibacterial resistance, new BIO report says https://t.co/LStFw4KMNb

[Access to Medicine Foundation @AtMIndex]

Tonight, leading experts will discuss the latest estimates of the AMR burden #GRAMpaper. This year, #AMRSOS will stay high on our agenda as our latest AMR Benchmark identified concerning gaps in what pharma companies are doing to #Stopsuperbugs.👉 https://t.co/fWq5V1h9vw

[Pamela Spence @PamelaSpence_EY]

AI and machine learning are set to have a measurable impact on drug development, clinical trials, supply chain and commercial & regulatory processes. @arda_ph shares more on our new solution, EY #SmartReviewer: https://t.co/YTXf47EDDz

[Manica Balasegaram @Manica_amr]

Au final, ce que montre cette étude c’est que #antibiorésistance arrive partout dans le monde: par excès d’utilisation des #antibiotiques dans les pays riches et par manque d’accès dans les pays pauvres. Lisez mon entretrien avec @heidi_news en entier https://t.co/4dkcYYmh5H

[Access to Medicine Foundation @AtMIndex]

Must-read: #superbugs kill more than HIV. Access to RIGHT meds is 🔑or people resort to less optimal ones & bugs get more chance to become resistant. Yet our research found little movement by #pharma to ramp up access
👉https://t.co/2oX6eIK8d5
#AMRSOS #StopSuperbugs @TheLancet